Ivan Diaz-Padilla

Ivan Diaz-Padilla

UNVERIFIED PROFILE

Are you Ivan Diaz-Padilla?   Register this Author

Register author
Ivan Diaz-Padilla

Ivan Diaz-Padilla

Publications by authors named "Ivan Diaz-Padilla"

Are you Ivan Diaz-Padilla?   Register this Author

20Publications

443Reads

33Profile Views

Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer.

Cancer 2015 Feb 2;121(3):413-22. Epub 2014 Oct 2.

CHU-de-Québec, Quebec City, Quebec, Canada; Division of Medical Oncology and Haematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755141PMC
February 2015

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

J Clin Oncol 2014 Oct 15;32(30):3374-82. Epub 2014 Sep 15.

Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus, Dresden, Germany; Anne Floquet, Isabelle Ray-Coquard, Marie-Ange Mouret-Reynier, Anne Lesoin, Eric Pujade-Lauraine, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers Ovariens; Anne Floquet, Institut Bergonié, Bordeaux; Isabelle Ray-Coquard, Centre Léon Bérard, Lyon; Marie-Ange Mouret-Reynier, Centre Jean Perrin, Clermont-Ferrand; Anne Lesoin, Centre Oscar Lambret, Lille; Eric Pujade-Lauraine, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, Paris, France; Jae-Weon Kim, Jae-Hoon Kim, Korean Gynecologic Oncology Group; Jae-Weon Kim, Seoul National University; Jae-Hoon Kim, Yonsei University; Byoung-Gie Kim, Samsung Medical Center, Seoul, Republic of Korea; Josep M. del Campo, Ivan Diaz-Padilla, Spanish Ovarian Cancer Research Group; Josep M. del Campo, Vall d'Hebron University Hospital, Barcelona; Ivan Diaz-Padilla, Centro Integral Oncologico Clara Campal, HM Hospitales, Madrid, Spain; Michael Friedlander, Paul Vasey, Australian and New Zealand Gynecological Oncology Group; Michael Friedlander, The Prince of Wales Clinical School University of New South Wales, Randwick, New South Wales; Paul Vasey, Wesley Medical Centre, Auchenflower, Queensland, Australia; Sandro Pignata, Giovanni Scambia, Multicenter Italian Trials in Ovarian Cancer; Sandro Pignata, Istituto Nazionale Tumori Fondazione G. Pascale, Naples; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan-Bicocca and European Institute of Oncology, Milan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7348DOI Listing
October 2014

Circulating and disseminated tumor cells in ovarian cancer: a systematic review.

Gynecol Oncol 2014 Jun 19;133(3):632-9. Epub 2014 Mar 19.

Division of Medical Oncology, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.03.016DOI Listing
June 2014

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

J Natl Cancer Inst 2014 Jan 22;106(1):djt319. Epub 2013 Nov 22.

Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA); Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS); Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt319DOI Listing
January 2014

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.

Ecancermedicalscience 2013 Dec 17;7:379. Epub 2013 Dec 17.

Gynaecology Oncology Programme, Medical Oncology, Comprehensive Oncology Centre Clara Campal, HM Hospitals, Madrid 28050, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2013.379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869475PMC
December 2013

Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.

Crit Rev Oncol Hematol 2013 Oct 4;88(1):154-67. Epub 2013 Apr 4.

Division of Medical Oncology, Centro Integral Oncologico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain; Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.03.002DOI Listing
October 2013

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors.

Invest New Drugs 2013 Oct 17;31(5):1182-91. Epub 2013 Jul 17.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, 610 University Avenue, 5-125, M5G 2M9, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-013-0001-5
Publisher Site
http://dx.doi.org/10.1007/s10637-013-0001-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771370PMC
October 2013

Treatment of metastatic cervical cancer: future directions involving targeted agents.

Crit Rev Oncol Hematol 2013 Mar 9;85(3):303-14. Epub 2012 Aug 9.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.07.006DOI Listing
March 2013

Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer.

Cancer Treat Rev 2012 Oct 29;38(6):767-75. Epub 2012 Feb 29.

Division of Medical Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.02.001DOI Listing
October 2012

Ovarian low-grade serous carcinoma: a comprehensive update.

Gynecol Oncol 2012 Aug 30;126(2):279-85. Epub 2012 Apr 30.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.04.029DOI Listing
August 2012

Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.

Gynecol Oncol 2012 Feb 6;124(2):354-65. Epub 2011 Nov 6.

Division of Medical Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.10.034DOI Listing
February 2012

Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls.

Clin Transl Oncol 2012 Jan;14(1):15-20

Division of Medical Oncology, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid--Norte Sanchinarro, Madrid, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12094-012-0756
Web Search
January 2012

Brivanib alaninate for cancer.

Expert Opin Investig Drugs 2011 Apr 11;20(4):577-86. Epub 2011 Mar 11.

Princess Margaret Hospital, Toronto, Ontario, M5G2M9 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.565329DOI Listing
April 2011

Epothilones in the treatment of ovarian cancer.

Future Oncol 2011 Apr;7(4):559-68

Princess Margaret Hospital, Bras Family Drug Development Program, Division of Medical Oncology, 610 University Avenue, Room 5-700, Toronto, ON M5G 2M9, Canada.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon.11.26
Publisher Site
http://dx.doi.org/10.2217/fon.11.26DOI Listing
April 2011

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.

Cochrane Database Syst Rev 2011 Mar 16(3):CD007584. Epub 2011 Mar 16.

Department of Medical Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, Canada, M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD007584.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171002PMC
March 2011

Cyclin-dependent kinase inhibitors as potential targeted anticancer agents.

Invest New Drugs 2009 Dec 5;27(6):586-94. Epub 2009 Mar 5.

Medical Oncology Department, Centro Integral Oncologico Clara Campal, C/ Oña 10, 28050, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9236-6DOI Listing
December 2009